Literature DB >> 21820208

Early prevention of pressure ulcers among elderly patients admitted through emergency departments: a cost-effectiveness analysis.

Ba' Pham1, Laura Teague, James Mahoney, Laurie Goodman, Mike Paulden, Jeff Poss, Jianli Li, Luciano Ieraci, Steven Carcone, Murray Krahn.   

Abstract

STUDY
OBJECTIVE: Every year, approximately 6.2 million hospital admissions through emergency departments (ED) involve elderly patients who are at risk of developing pressure ulcers. We evaluated the cost-effectiveness of pressure-redistribution foam mattresses on ED stretchers and beds for early prevention of pressure ulcers in elderly admitted ED patients.
METHODS: Using a Markov model, we evaluated the incremental effectiveness (quality-adjusted life-days) and incremental cost (hospital and home care costs) between early prevention and current practice (with standard hospital mattresses) from a health care payer perspective during a 1-year time horizon.
RESULTS: The projected incidence of ED-acquired pressure ulcers was 1.90% with current practice and 1.48% with early prevention, corresponding to a number needed to treat of 238 patients. The average upgrading cost from standard to pressure-redistribution mattresses was $0.30 per patient. Compared with current practice, early prevention was more effective, with 0.0015 quality-adjusted life-days gained, and less costly, with a mean cost saving of $32 per patient. If decisionmakers are willing to pay $50,000 per quality-adjusted life-year gained, early prevention was cost-effective even for short ED stay (ie, 1 hour), low hospital-acquired pressure ulcer risk (1% prevalence), and high unit price of pressure-redistribution mattresses ($3,775). Taking input uncertainty into account, early prevention was 81% likely to be cost-effective. Expected value-of-information estimates supported additional randomized controlled trials of pressure-redistribution mattresses to eliminate the remaining decision uncertainty.
CONCLUSION: The economic evidence supports early prevention with pressure-redistribution foam mattresses in the ED. Early prevention is likely to improve health for elderly patients and save hospital costs.
Copyright © 2011 American College of Emergency Physicians. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21820208     DOI: 10.1016/j.annemergmed.2011.04.033

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  5 in total

1.  The cost-benefit of using soft silicone multilayered foam dressings to prevent sacral and heel pressure ulcers in trauma and critically ill patients: a within-trial analysis of the Border Trial.

Authors:  Nick Santamaria; Wei Liu; Marie Gerdtz; Sarah Sage; Jane McCann; Amy Freeman; Theresa Vassiliou; Stephanie DeVincentis; Ai W Ng; Elizabeth Manias; Jonathan Knott; Danny Liew
Journal:  Int Wound J       Date:  2013-10-06       Impact factor: 3.315

Review 2.  Support surfaces for pressure ulcer prevention.

Authors:  Elizabeth McInnes; Asmara Jammali-Blasi; Sally E M Bell-Syer; Jo C Dumville; Victoria Middleton; Nicky Cullum
Journal:  Cochrane Database Syst Rev       Date:  2015-09-03

3.  Prevention of deep tissue injury through muscle contractions induced by intermittent electrical stimulation after spinal cord injury in pigs.

Authors:  Leandro R Solis; Elizabeth Twist; Peter Seres; Richard B Thompson; Vivian K Mushahwar
Journal:  J Appl Physiol (1985)       Date:  2012-11-21

4.  Pressure ulcers in palliative ward patients: hyponatremia and low blood pressure as indicators of risk.

Authors:  Danuta Sternal; Krzysztof Wilczyński; Jan Szewieczek
Journal:  Clin Interv Aging       Date:  2016-12-29       Impact factor: 4.458

5.  Value of hospital resources for effective pressure injury prevention: a cost-effectiveness analysis.

Authors:  William V Padula; Peter J Pronovost; Mary Beth F Makic; Heidi L Wald; Dane Moran; Manish K Mishra; David O Meltzer
Journal:  BMJ Qual Saf       Date:  2018-08-10       Impact factor: 7.035

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.